NFKB1 and breast cancer: Moreover, MUC1-CT is also shown to modulate activity of the nuclear factor kappa B (NF-κB) pathway in breast cancer cells by interacting with and activating IkB kinase (IKK) family members and NF-κB p65 [15,16,17].